Dr. Mileham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009- Vanderbilt University Medical CenterResidency, Internal Medicine, 2003 - 2006
Medical University of South CarolinaClass of 2003
Certifications & Licensure
NC State Medical License 2009 - 2025
TN State Medical License 2006 - 2010- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Early Diagnosis of Pulmonary Nodules Start of enrollment: 2012 Oct 01
- LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer Start of enrollment: 2014 Dec 01
- A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) Start of enrollment: 2015 May 06
Publications & Presentations
PubMed
- 136 citationsEarly Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncol...David M. Waterhouse, R. Donald Harvey, Patricia Hurley, Laura A. Levit, Edward S. Kim
JCO Oncology Practice. 2020-05-12 - 34 citationsDefining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.Kathryn F Mileham, Caroline Schenkel, Suanna S Bruinooge, Janet Freeman-Daily, Upal Basu Roy
Cancer Medicine. 2022-01-01 - 47 citationsClinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.Sonali M. Smith, Kerri Wachter, Howard A. Burris, Richard L. Schilsky, Daniel J. George
Journal of Clinical Oncology. 2021-02-02
Authored Content
- Moving Away (Finally) from Doublet Therapy in Lung Cancer: Immunotherapy and KEYNOTE-189September 2018
Press Mentions
COVID-19 Mortality Risk Higher Among Older Patients with B-cell MalignanciesJanuary 6th, 2022- GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung CancerDecember 21st, 2021
Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsApril 15th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
